myeloid leukemia

Pharma

Novartis wins CML nod for new Gleevec follow-on Scemblix

Novartis’ oncology chief Susanne Schaffert, Ph.D., said Scemblix has blockbuster potential in third-line CML alone.

Angus Liu Nov 1, 2021 6:51am

Takeda HQ

Takeda pads case for new leukemia use with 5-year survival data

Dec 8, 2020 8:35am

tonaquaticGettyImages

Astex's Inqovi nod gives patients on decitabine a non-IV option

Aug 3, 2020 8:00am

AstraZeneca

AZ's Calquence chases Imbruvica with phase 3 leukemia win

May 7, 2019 11:40am